Bridgewater, NJ (USA), January 30, 2017 – Safre Pharmaceuticals LLC has launched Metformin Hydrochloride Tablets, 500 mg, 850 mg and 1000 mg, a generic equivalent to Glucophage. The product began shipping in bulk and multiple unit size bottles on April 1, 2017 through wholesalers, distributors and directly to the trade.
We’re very pleased to add Metformin HCl Tablets to our growing portfolio of high-quality, affordable medicines.
Safrel Pharmaceuticals (www.safrelpharma.com),is dedicated to the commercialization of specialty pharmaceuticals such as oncologics, anti-infectives and supportive care for healthcare providers and patients of all ages. The company’s expertise and focus on the unique needs and logistics of this market ensure the same level of quality and service for healthcare institutions and professionals that Safrel delivers to its retail customers.
